Nazione: Svizzera
Lingua: tedesco
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
glofitamabum
Roche Pharma (Schweiz) AG
L01FX
glofitamabum
Konzentrat zur Herstellung einer Infusionslösung
glofitamabum 2.5 mg, histidinum, histidini hydrochloridum monohydricum, methioninum, saccharum, polysorbatum 20, aqua ad iniectabile, q.s. ad solutionem pro 2.5 ml.
A
Biotechnologika
diffuses grosszelliges B-Zell Lymphom
befristet
2023-07-11